Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta-analysis and metaregression.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology - 1 Nov 2023

Singh Ashutosh Kumar, Alagarsamy Ragavi, Chaulagain Rajib, Singh Abanish, Sapkota Dipak, Thavaraj Selvam, Singh Rabindra P

Abstract excerpt

OBJECTIVES: This review aims to analyse the recurrence rate in BRAFv600e+ and BRAFv600e- ameloblastomas and explore its association with clinicopathological variables. METHODS: A comprehensive search was conducted using databases including PubMed, Embase, Cochrane Central Register of Controlled Trials, Clinicaltrials.gov, Google Scholar and grey literature, without any limitation on start date or language up to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ameloblastoma
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 37872712
DOI: 10.1111/jop.13494

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta-analysis and metaregression.PMID 37872712Read ↗

Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis.Semantic proximity Read ↗

Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres.Semantic proximity Read ↗

Prevalence and clinicopathological correlation of BRAF V600E mutations in ameloblastoma: A PCR study from a tertiary centre in South India.Semantic proximity Read ↗

High frequency of BRAF V600E mutation in Iranian population ameloblastomas.Semantic proximity Read ↗

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses.Semantic proximity Read ↗

Precision therapy for BRAF V600E-mutated ameloblastoma: Systematic review insights.Semantic proximity Read ↗

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read ↗

Differential Profile of Primary and Recurrent Ameloblastomas Among Afro-descendants and Non-Afro-descendants-a Systematic Review.Semantic proximity Read ↗

BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.Semantic proximity Read ↗

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.Semantic proximity Read ↗

Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma.Semantic proximity Read ↗

The landscape of genetic alterations in ameloblastomas relates to clinical features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.